Distinct assembly profiles of HLA-B molecules syed monem rizvi1

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 4967-4976

  Salam, Nasir ^a,i   Geng, Jie ^a   Qi, Ying ^b,c   Bream, Jay H ^d   Duggal, Priya ^d   Hussain, Shehnaz K ^e,f   Martinson, Jeremy ^g   Wolinsky, Steven M ^h   Carrington, Mary ^b,c   Raghavan, Malini ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TAPASIN;

ALLOTYPE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISEASE ASSOCIATION; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STABILITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGEN PRESENTATION; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GENETIC LOCI; HIV-1; HLA-B ANTIGENS; HUMANS; MEMBRANE TRANSPORT PROTEINS; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN FOLDING;

EID: 84901290106     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301670     Document Type: Article

References (58)

1. Neefjes, J., M. L. Jongsma, P. Paul, and O. Bakke. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11: 823-836.
2. Campbell, K. S., and A. K. Purdy. 2011. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132: 315-325.
3. Carrington, M., and B. D. Walker. 2012. Immunogenetics of spontaneous control of HIV. Annu. Rev. Med. 63: 131-145.
4. Goulder, P. J., and B. D. Walker. 2012. HIV and HLA class I: an evolving relationship. Immunity 37: 426-440.
5. Jamil, K. M., and S. I. Khakoo. 2011. KIR/HLA interactions and pathogen immunity. J. Biomed. Biotechnol. 2011: 298348.
6. Reveille, J. D. 2012. Genetics of spondyloarthritis - beyond the MHC. Nat. Rev. Rheumatol. 8: 296-304.
7. Pereyra, F., X. Jia, P. J. McLaren, A. Telenti, P. I. de Bakker, B. D. Walker, S. Ripke, C. J. Brumme, S. L. Pulit, M. Carrington, et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
8. Fellay, J., K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M. Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
9. Ljunggren, H. G., N. J. Stam, C. Ohlén, J. J. Neefjes, P. Höglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, K. Kärre, et al. 1990. Empty MHC class I molecules come out in the cold. Nature 346: 476-480.
10. Blum, J. S., P. A. Wearsch, and P. Cresswell. 2013. Pathways of antigen processing. Annu. Rev. Immunol. 31: 443-473.
11. Abele, R., and R. Tampé. 2011. The TAP translocation machinery in adaptive immunity and viral escape mechanisms. Essays Biochem. 50: 249-264.
12. Li, S., H. O. Sjögren, U. Hellman, R. F. Pettersson, and P. Wang. 1997. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 94: 8708-8713.
13. Ortmann, B., J. Copeman, P. J. Lehner, B. Sadasivan, J. A. Herberg, A. G. Grandea, S. R. Riddell, R. Tampé, T. Spies, J. Trowsdale, and P. Cresswell. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277: 1306-1309.
14. Dong, G., P. A. Wearsch, D. R. Peaper, P. Cresswell, and K. M. Reinisch. 2009. Insights into MHC class I peptide loading from the structure of the tapasin- ERp57 thiol oxidoreductase heterodimer. Immunity 30: 21-32.
15. Peaper, D. R., P. A. Wearsch, and P. Cresswell. 2005. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J. 24: 3613-3623.
16. Del Cid, N., E. Jeffery, S. M. Rizvi, E. Stamper, L. R. Peters, W. C. Brown, C. Provoda, and M. Raghavan. 2010. Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway. J. Biol. Chem. 285: 4520-4535.
17. Rizvi, S. M., N. Del Cid, L. Lybarger, and M. Raghavan. 2011. Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules. J. Immunol. 186: 2309-2320.
18. Rizvi, S. M., and M. Raghavan. 2010. Mechanisms of function of tapasin, a critical major histocompatibility complex class I assembly factor. Traffic 11: 332-347.
19. Wearsch, P. A., and P. Cresswell. 2007. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin- ERp57 heterodimer. Nat. Immunol. 8: 873-881.
20. Wearsch, P. A., D. R. Peaper, and P. Cresswell. 2011. Essential glycan-dependent interactions optimize MHC class I peptide loading. Proc. Natl. Acad. Sci. USA 108: 4950-4955.
21. Solheim, J. C., M. R. Harris, C. S. Kindle, and T. H. Hansen. 1997. Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158: 2236-2241.
22. Rizvi, S. M., and M. Raghavan. 2006. Direct peptide-regulatable interactions between MHC class I molecules and tapasin. Proc. Natl. Acad. Sci. USA 103: 18220-18225.
23. Zarling, A. L., C. J. Luckey, J. A. Marto, F. M. White, C. J. Brame, A. M. Evans, P. J. Lehner, P. Cresswell, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 2003. Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J. Immunol. 171: 5287-5295.
24. Chen, M., and M. Bouvier. 2007. Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection. EMBO J. 26: 1681-1690.
25. Williams, A. P., C. A. Peh, A. W. Purcell, J. McCluskey, and T. Elliott. 2002. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16: 509-520.
26. Howarth, M., A. Williams, A. B. Tolstrup, and T. Elliott. 2004. Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc. Natl. Acad. Sci. USA 101: 11737-11742.
27. Peh, C. A., S. R. Burrows, M. Barnden, R. Khanna, P. Cresswell, D. J. Moss, and J. McCluskey. 1998. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8: 531-542.
28. Zernich, D., A. W. Purcell, W. A. Macdonald, L. Kjer-Nielsen, L. K. Ely, N. Laham, T. Crockford, N. A. Mifsud, M. Bharadwaj, L. Chang, et al. 2004. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. 200: 13-24.
29. Thammavongsa, V., G. Raghuraman, T. M. Filzen, K. L. Collins, and M. Raghavan. 2006. HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J. Immunol. 177: 3150-3161.
30. Thammavongsa, V., M. Schaefer, T. Filzen, K. L. Collins, M. Carrington, N. Bangia, and M. Raghavan. 2009. Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503. Immunogenetics 61: 703-716.
31. Stols, L., M. Gu, L. Dieckman, R. Raffen, F. R. Collart, and M. I. Donnelly. 2002. A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. Protein Expr. Purif. 25: 8-15.
32. Belicha-Villanueva, A., S. McEvoy, K. Cycon, S. Ferrone, S. O. Gollnick, and N. Bangia. 2008. Differential contribution of TAP and tapasin to HLA class I antigen expression. Immunology 124: 112-120.
33. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14: 9-20.
34. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
35. Kao, K. J., and W. J. Riley. 1993. Genetic predetermination of quantitative expression of HLA antigens in platelets and mononuclear leukocytes. Hum. Immunol. 38: 243-250.
36. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429-3433.
37. Phair, J., L. Jacobson, R. Detels, C. Rinaldo, A. Saah, L. Schrager, and A. Muñoz. 1992. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 5: 490-496.
38. Goedert, J. J., C. M. Kessler, L. M. Aledort, R. J. Biggar,W. A. Andes, G. C.White, II, J. E. Drummond, K. Vaidya, D. L. Mann, M. E. Eyster, et al. 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N. Engl. J. Med. 321: 1141-1148.
39. Goedert, J. J., R. J. Biggar, D. M. Winn, D. L. Mann, D. P. Byar, D. M. Strong, R. A. DiGioia, R. J. Grossman, W. C. Sanchez, R. G. Kase, et al. 1985. Decreased helper T lymphocytes in homosexual men. I. Sexual contact in highincidence areas for the acquired immunodeficiency syndrome. Am. J. Epidemiol. 121: 629-636.
40. Badrinath, S., P. Saunders, T. Huyton, S. Aufderbeck, O. Hiller, R. Blasczyk, and C. Bade-Doeding. 2012. Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes. Haematologica 97: 98-106.
41. Geironson, L., C. Thuring, M. Harndahl, M. Rasmussen, S. Buus, G. Røder, and K. M. Paulsson. 2013. Tapasin facilitation of natural HLA-A and -B allomorphs is strongly influenced by peptide length, depends on stability, and separates closely related allomorphs. J. Immunol. 191: 3939-3947.
42. Muller, C. A., G. Engler-Blum, V. Gekeler, I. Steiert, E. Weiss, and H. Schmidt. 1989. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 30: 200-207.
43. Sidney, J., B. Peters, N. Frahm, C. Brander, and A. Sette. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9: 1.
44. Hillen, N., G. Mester, C. Lemmel, A. O. Weinzierl, M. Muller, D. Wernet, J. Hennenlotter, A. Stenzl, H. G. Rammensee, and S. Stevanović. 2008. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype. Eur. J. Immunol. 38: 2993-3003.
45. Macdonald, W., D. S. Williams, C. S. Clements, J. J. Gorman, L. Kjer-Nielsen, A. G. Brooks, J. McCluskey, J. Rossjohn, and A. W. Purcell. 2002. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex. FEBS Lett. 527: 27-32.
46. Falk, K., O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanović, G. Jung, and H. G. Rammensee. 1993. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38: 161-162.
47. Steinle, A., K. Falk, O. Rötzschke, V. Gnau, S. Stevanović, G. Jung, D. J. Schendel, and H. G. Rammensee. 1996. Motif of HLA-B*3503 peptide ligands. Immunogenetics 43: 105-107.
48. Sakaguchi, T., M. Ibe, K. Miwa, Y. Kaneko, S. Yokota, K. Tanaka, and M. Takiguchi. 1997. Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules (HLA-B*5101). Immunogenetics 45: 259-265.
49. Kubo, H., Y. Ikeda-Moore, A. Kikuchi, K. Miwa, K. Nokihara, C. Schönbach, and M. Takiguchi. 1998. Residue 116 determines the C-terminal anchor residue of HLA-B*3501 and -B*5101 binding peptides but does not explain the general affinity difference. Immunogenetics 47: 256-263.
50. Tomiyama, H., N. Yamada, H. Komatsu, K. Hirayama, and M. Takiguchi. 2000. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules. Eur. J. Immunol. 30: 2521-2530.
51. Vivian, J. P., R. C. Duncan, R. Berry, G. M. O'Connor, H. H. Reid, T. Beddoe, S. Gras, P. M. Saunders, M. A. Olshina, J. M. Widjaja, et al. 2011. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479: 401-405.
52. Macdonald, W. A., A. W. Purcell, N. A. Mifsud, L. K. Ely, D. S. Williams, L. Chang, J. J. Gorman, C. S. Clements, L. Kjer-Nielsen, D. M. Koelle, et al. 2003. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198: 679-691.
53. Hill, A., M. Takiguchi, and A. McMichael. 1993. Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain. Immunogenetics 37: 95-101.
54. Khanna, R., S. R. Burrows, A. Neisig, J. Neefjes, D. J. Moss, and S. L. Silins. 1997. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines. J. Virol. 71: 7429-7435.
55. Sieker, F., S. Springer, and M. Zacharias. 2007. Comparative molecular dynamics analysis of tapasin-dependent and -independent MHC class I alleles. Protein Sci. 16: 299-308.
56. Kanaseki, T., K. C. Lind, H. Escobar, N. Nagarajan, E. Reyes-Vargas, B. Rudd, A. L. Rockwood, L. Van Kaer, N. Sato, J. C. Delgado, and N. Shastri. 2013. ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J. Immunol. 191: 1547-1555.
57. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213.
58. Flores-Villanueva, P. O., E. J. Yunis, J. C. Delgado, E. Vittinghoff, S. Buchbinder, J. Y. Leung, A. M. Uglialoro, O. P. Clavijo, E. S. Rosenberg, S. A. Kalams, et al. 2001. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA 98: 5140-5145.